The US FDA Approves Biocon Biologics’ Jobevne (Biosimilar, Avastin)

Shots:The US FDA has approved Jobevne, a biosimilar version of Avastin (bevacizumab) for IV administrationApproval was based on extensive data showing Jobevne is similar to Avastin in PK, safety, efficacy, structure, & function across clinical & analytical studiesJobevne (VEGF inhibitor) is marketed under the brand name Abevmy in the EU & Canada,…